AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C.
It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants.
AbbVie Inc. researches and develops pharmaceutical products.
Address: 1 North Waukegan Road North Chicago, IL 60064 United States
Phone Number: 1-847-932-7900
Website: www.abbvie.com
Company Overview of AbbVie Inc.
| Traded as | NYSE: ABBV |
| Industry | Biopharmaceutical |
| Founded | 2013; 6 years ago |
| Headquarters | Lake Bluff, Illinois, United States |
| Area served | Worldwide |
| Key people | Richard A. Gonzalez (Chairman & CEO) |
Products Pharmaceutical drugs
- Humira (adalimumab)
- Imbruvica (ibrutinib)
- Venclexta (venetoclax)
- Zinbryta (daclizumab)
- Kaletra (lopinavir)
- Norvir (ritonavir)
- Mavyret/Maviret (glecaprevir/pibrentasvir)
Where is AbbVie located?
Pharmaceutical Contract Manufacturing Locations in United States (USA), Ireland, Germany, Italy, Puerto Rico – AbbVie Contract Manufacturing.
